United States NIPT Market

United States | NIPT | Diagnostics | Market Overview

DPI Research published a new report on United States Non Invasive Prenatal Testing Market. The research offers an extensive analysis of key players active in the United States Non Invasive Prenatal Testing Market. Detailed analysis on operating business segments, product portfolio, business performance, and key strategic developments is offered in the research. Leading market players analyzed in the report include: Illumina, Natera, Quest Diagnostics, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche)

Download Free Sample Report: https://dpiresearch.com/request-a-free-sample-report/

“United States Non-Invasive Prenatal Testing (NIPT) Market Analysis (Actual and Potential), By Pregnancy Risk Level (High & Average Risk), Major Deals, Reimbursement, Key Company Profiles & Demand Forecasts to 2018 – 2023” examines the market dynamics, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for NIPT test in the United States. The research includes historic data from 2015 to 2017 and forecasts until 2023.

Long–term Growth Projection:

  • United States is anticipated to be the most attractive market in the Non-Invasive Prenatal Testing(NIPT) industry
  • United States Non-Invasive Prenatal Testing(NIPT) is expected to register a faster value growth during 2018 – 2023
  • The Potential United States Non-Invasive Prenatal Testing(NIPT) Market is set to cross USD 2.5 Billion by 2023
  • MaterniT21 PLUS, Harmony, Verifi, Panorama are the popular test in the United States Non-Invasive Prenatal Testing(NIPT) Market

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2023. The report also includes an assessment of comparative test analysis by companies. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT test market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution, and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market.

The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market.

Enquire for customization in Report @: https://dpiresearch.com/services/custom-research-services-providing-focused-comprehensive-tailored-research/

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Illumina, Natera, Quest Diagnostics, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche)

Major and Promising NIPT test covered in the report are as follows:

MaterniT21 PLUS, VisibiliT, MaterniT21 GENOME, Harmony, Verifi, Panorama, Vistara and QNatal Advanced

The Latest Industry Data Included in this Report:

  • Actual NIPT Test Volume & Market Revenue (2015 – 2023)
  • Average Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
  • High-Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
  • Potential NIPT Test Volume & Market Revenue (2015 – 2023)
  • Average Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
  • High-Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
  • NIPT Test Market – Reimbursement & Regulation System
  • NIPT Test Implementation in High–Income Countries
  • Comparative Test Analysis – By Companies
  • Major Deals in Non–Invasive Prenatal Testing Market
  • Key Companies Analysis
  • Key Market Drivers and Inhibitors of the United States NIPT Test Market

For More Information@ https://dpiresearch.com/reports/united-states-non-invasive-prenatal-testing-market/

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@dpiresearch.com

Customization of the Report:

DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Contact Us:
Maria Rai
Head of Business Development
DPI Research | Web: https://dpiresearch.com
Direct Line: +91-766-764-8693
E-mail: sales@dpiresearch.com

About Us:

DPI Research is a leading market research publisher which offer bespoke market research reports, custom research and consulting services across multi geographies and industry verticals. We deliver a wide range of cutting-edge research solutions that help organizations in making better decisions of the business to business needs.

DPI Research provides a high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to using advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for business research led by a team of dynamic industry experts. DPI Research provides real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reaches across the globe with global standards from established markets in North America and Europe to emerging markets in South America, Asia-Pacific, Middle East, and Africa to provide the best business solutions.

Spread the love

Leave a Reply

Your email address will not be published.